Margo Heath-Chiozzi, M.D., is a distinguished professional serving as the Senior Vice President of Regulatory Affairs at Celldex Therapeutics Inc. Dr. Heath-Chiozzi brings a wealth of experience to her role, having spent over two decades in the biopharmaceutical industry. She earned her medical degree from the University of Maryland School of Medicine and completed her residency in internal medicine at the University of California, San Francisco. Her career trajectory includes significant roles at major pharmaceutical companies, where she has demonstrated expertise in navigating the complex regulatory landscapes essential for bringing innovative therapies to market. In her current position at Celldex Therapeutics, Dr. Heath-Chiozzi is responsible for overseeing the company's regulatory strategies and ensuring compliance with global regulatory requirements. Her leadership has been instrumental in advancing Celldex's pipeline of immunotherapy and targeted therapies aimed at treating severe diseases such as cancer and autoimmune disorders. Prior to joining Celldex, she held pivotal positions at companies like Amgen and Bristol-Myers Squibb, where she successfully led regulatory teams in securing approvals for multiple groundbreaking treatments. Her strategic insight and dedication to patient safety have earned her a reputation as a respected leader in the field of regulatory affairs. Dr. Heath-Chiozzi's contributions to the biopharmaceutical industry extend beyond her corporate roles. She is an active member of several professional organizations, including the Drug Information Association and the Regulatory Affairs Professionals Society, where she shares her knowledge and mentors the next generation of regulatory professionals. Her commitment to advancing medical science and improving patient outcomes continues to drive her work at Celldex Therapeutics, where she plays a crucial role in the company's mission to develop life-changing therapies.